找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Hodgkin‘s and Non-Hodgkin‘s Lymphoma; John P. Leonard,Morton Coleman Book 2006 Springer-Verlag US 2006 Tumor.blood.bone.bone marrow.cell.d

[复制链接]
楼主: Awkward
发表于 2025-3-25 03:41:01 | 显示全部楼层
发表于 2025-3-25 10:48:44 | 显示全部楼层
Cancer Treatment and Researchhttp://image.papertrans.cn/h/image/427834.jpg
发表于 2025-3-25 15:14:30 | 显示全部楼层
,Management of Advanced Stage Hodgkin’s Lymphoma,Hodgkin’s lymphoma (HL) is an uncommon malignancy of unknown etiology with an annual incidence in Western populations of 2–3 per 100,000 (.). On average there are 7000 new cases reported in the United States each year, distributed in a bimodal pattern with a first peak in the third decade and a second peak after the age of 50 (., .).
发表于 2025-3-25 16:53:56 | 显示全部楼层
,Pathology of B-Cell Non-Hodgkin’s Lymphomas and Multiple Myeloma,L/SLL), appear to resemble more than one B-cell differentiation stage. Nevertheless, a basic understanding of B-cell differentiation stages and their associated immunophenotypic characteristics facilitates accurate diagnosis and appropriate management of B-NHLs.
发表于 2025-3-25 21:11:38 | 显示全部楼层
Diffuse Large B-Cell NHL, play a role in the development of new prognostic models that may refine our ability to identify poor-risk patients. With this technology, over the next decade, it is hoped that novel therapeutic targets will be identified, allowing continued improvements in outcome for patients with this disease.
发表于 2025-3-26 04:02:00 | 显示全部楼层
发表于 2025-3-26 07:16:58 | 显示全部楼层
发表于 2025-3-26 10:22:28 | 显示全部楼层
,Monoclonal Antibodies in the Treatment of Non-Hodgkin’s Lymphoma,of a series of differentiation antigens, termed “cluster of differentiation” (CD) antigens. These characteristics serve as the basis for the World Health Organization (WHO) Classification of Lymphoid Neoplasms [.]. These proteins are also valuable markers for diagnosing and classifying lymphomas, as well as reliable targets for therapy.
发表于 2025-3-26 15:04:42 | 显示全部楼层
,Blood and Bone Marrow Transplantation for Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma,) for patients with lymphoma. Initial studies were performed in refractory patients. These studies demonstrated the feasibility of this approach and ushered in more definitive trials in patients with homogenous histologies.
发表于 2025-3-26 20:15:57 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-4 05:34
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表